One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Causal inference using regression discontinuity analysis: what can the nephrologist learn from herpes zoster vaccination?
GWAS moves endothelin directly to vascular smooth muscle and blood pressure regulation
RNA methylation in acute kidney injury: opening up new therapeutic avenues
Pathologic diagnosis incorporating molecular monitoring highlights new pathophysiological mechanisms in kidney xenotransplantation
Percentiles of estimating glomerular filtration rate: a new personalized tool for detection of chronic kidney disease
The expanding role of complement inhibitors in the treatment of IgA nephropathy
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Meta-organismal tryptophan metabolism: an appealing therapeutic target in CKD-MBD
Utilizing risk prediction models for older patients with chronic kidney disease
Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors
The m7G methyltransferase METTL1 promotes acute kidney inflammation by disrupting mitochondrial function
Mechanistic insights from transcript analysis of long-term pig to non-human primate kidney xenografts
Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction
Therapeutic reprogramming of circulating myeloid cells via signal regulatory protein α extracellular vesicles in acute kidney injury
Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease
Parathyroid hormone suppression profiles following oral calcium challenge in kidney transplant recipients
Complement activation drives a compartmentalized innate immune response in C3 glomerulopathy contributing to the disease phenotype
A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy
Challenges in revealing the true incidence of end-stage kidney disease in the elderly population
Reassessing pravastatin in adult autosomal dominant polycystic kidney disease and potential subgroup benefits
Causal claims require defined interventions: a note on the EQUAL chronic kidney disease–mineral and bone disorder analysis
Is it time to add a fifth pillar to the physical examination in pediatric dialysis?
Monoclonal versus monotypic: promoting awareness of terminology and clinical take-aways
Coexistence of autosomal dominant polycystic kidney disease and primary hyperoxaluria type 3
The Case | Flaccid paralysis and tetany after chemotherapy: a diagnostic challenge
The Case | Unexplained post-transplant graft dysfunction in a rare metabolic disorder
